Credit Suisse Ag Sesen Bio, Inc. Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
SELL
$0.0 - $0.93 $0 - $6
-7 Reduced 87.5%
1 $0
Q2 2022

Aug 12, 2022
BUY
$0.38 - $0.89 $3 - $7
8 New
8 $0
Q1 2020

May 13, 2020
SELL
$0.39 - $1.03 $97,989 - $258,793
-251,256 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
$0.89 - $1.5 $223,617 - $376,884
251,256 New
251,256 $261,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Sesen Bio, Inc.

SESN Quotes by TradingView
  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email